JAK2 and neoplasm: Given the synergistic effect of CHZ868 on CD19 CAR-T cells in JAK2 wild-type REH cells, we hypothesized that CHZ868 directly enhanced the anti-tumor function of CD19 CAR-T cells by modulating their characteristics during tumor interactions.